Literature DB >> 6140559

The Arjenyattah epidemic. A mass phenomenon: spread and triggering factors.

B Modan, T A Swartz, M Tirosh, C Costin, E Weissenberg, A Donagi, C Acker, M Revach, G Vettorazzi.   

Abstract

A massive epidemic of psychogenic aetiology occurred in three districts of the West Bank over two weeks in March-April, 1983. It affected 949 individuals, 727 (77%) of them adolescent females. The symptoms were not accompanied by positive physical signs or by laboratory findings. The epidemiological pattern was pathognomonic of that of a psychogenic disorder. The initial trigger was probably the odour of H2S escaping from a faulty latrine in the schoolyard of the first affected school. Subsequent spread of the disease was due to psychological and extra-medical factors, including publicity by the mass media. Spread was stopped immediately after closure of schools.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140559     DOI: 10.1016/s0140-6736(83)90814-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  A challenging empirical question: What are the effects of media on psychogenic illness during a community crisis?

Authors:  Elizabeth Bass; Evonne Kaplan-Liss; Dennis Dorf; Joan E Broderick
Journal:  J Community Med Health Educ       Date:  2012-01-01

2.  An outbreak of illness among schoolchildren in London: toxic poisoning not mass hysteria.

Authors:  J C Aldous; G A Ellam; V Murray; G Pike
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

3.  Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre-post observational study.

Authors:  Kate Faasse; Greg Gamble; Tim Cundy; Keith J Petrie
Journal:  BMJ Open       Date:  2012-08-17       Impact factor: 2.692

Review 4.  Mass psychogenic illness after vaccination.

Authors:  C John Clements
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.